Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals

scientific article published on 5 July 2012

Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/13693786.2012.698024
P698PubMed publication ID22762208
P5875ResearchGate publication ID228323372

P50authorMarcio NucciQ37837344
M GarnicaQ57017191
P2093author name stringArnaldo L Colombo
Luis Fernando Aranha Camargo
Ana Lucia Senna
Antonio Carlos Bandeira
Clovis Arns Da Cunha
Danielle Borghi
Maria Eugenia Valias Didier
Tatiana Campos
Viviane Carvalho Dias
P2860cites workDo in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.Q32122087
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registryQ33445758
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort studyQ33595137
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methodsQ33738435
Population ageing in developed and developing regions: implications for health policyQ34022897
Increasing incidence of candidemia: results from a 20-year nationwide study in IcelandQ34194192
Variation in critical care services across North America and Western EuropeQ34819861
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centersQ35073043
Epidemiology of opportunistic fungal infections in Latin America.Q37775629
Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.Q39795440
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance ProgramQ43118426
Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, SpainQ43135266
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and deathQ43142736
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).Q46072663
Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in BrazilQ46373998
Age as a basis for healthcare rationing. Support for agist policies.Q53612482
P433issue1
P921main subjectCandida glabrataQ139137
emerging pathogenQ108429945
P304page(s)38-44
P577publication date2012-07-05
P1433published inMedical MycologyQ6806389
P1476titleCandida glabrata: an emerging pathogen in Brazilian tertiary care hospitals
P478volume51

Reverse relations

cites work (P2860)
Q39684445Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin.
Q34492906Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
Q35903892Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program
Q38711698Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.
Q92772855Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study
Q34635088Epidemiology of candidemia in Latin America: a laboratory-based survey
Q53694044Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital.
Q35980145FREQUENCY OF Candida SPECIES IN A TERTIARY CARE HOSPITAL IN TRIANGULO MINEIRO, MINAS GERAIS STATE, BRAZIL.
Q36503873First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes.
Q47147760Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
Q40703127Imbalanced Macrophage and Dendritic Cell Activations in Response to Candida albicans in a Murine Model of Diabetes Mellitus
Q42252984Invasive candidosis: contrasting the perceptions of infectious disease physicians and intensive care physicians.
Q30841261Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey
Q46302196Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
Q34252030Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period
Q40090888Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata.
Q48523172Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers.
Q41887639Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates
Q34632356Trafficking of phagocytic peritoneal cells in hypoinsulinemic-hyperglycemic mice with systemic candidiasis

Search more.